Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-23 Sale |
2021-03-25 4:13 pm |
Gossamer Bio Inc. | GOSS | Salter-Cid Luisa Chief Scientific Officer |
5,491 | $9.4795 | $52,052 | 206,065 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-24 Option Award |
2022-06-28 9:08 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | Salter-Cid Luisa Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:50 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | Salter-Cid Luisa Director |
7,850 | $0 | 7,850 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:54 pm |
N/A 2031-02-25 |
Gossamer Bio Inc. | GOSS | Salter-Cid Luisa Chief Scientific Officer |
135,000 | $0 | 301,556 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 08:10 am |
N/A 2031-02-10 |
Jounce Therapeutics Inc. | JNCE | Salter-Cid Luisa Director |
31,400 | $0 | 31,400 (Direct) |
View |